Harvard Apparatus Regenerative Technology HRGN
OTC HRGN
$1.97 -0.09 (-4.37%)
At close: Oct 22, 2026 · 4:00 PM EDT

Harvard Apparatus Regenerative Technology (HRGN) Construction in Progress (2016)

Updated

Harvard Apparatus Regenerative Technology (HRGN) posted Construction in Progress of $108,000 for Q4 2016.

Analysis

Harvard Apparatus Regenerative Technology (HRGN) Construction in Progress (2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn -
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn -
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn -
10 Harvard Apparatus Regenerative Technology 34.63 Mn 31.14 Mn 23,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 108,000.00
API Access

Harvard Apparatus Regenerative Technology Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=HRGN&period=max&api_key=YOUR_API_KEY